Medindia

X

Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine

by Dr. Trupti Shirole on  January 7, 2015 at 12:53 PM Clinical Trials News   - G J E 4
US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola. The company is hoping to move on to studies on large groups of patients by April.
 Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine
Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine
Advertisement

The Oxford Vaccine Group at Britain's Oxford University is carrying out Phase I testing of the Ebola vaccine. 72 healthy volunteers are part of the test that will examine how their bodies tolerate the potential vaccine.

Advertisement
Johnson & Johnson said, "At the end of October we would spend up to $200 million to speed up and expand our Ebola vaccine program. We have already produced more than 400,000 doses, and two million courses will be ready by the year end. If necessary we can make five million doses within 12 to 18 months."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like